毕业于北京大学医学部，2012-8在北京大学肿瘤医院工作至今。擅长晚期肺癌的综合治疗及临床研究的相关诊疗等。作为主要研究者参与多项国内外临床研究。目前担任中国老年学和老年医学学会肿瘤康复分会精准医疗专家委员会委员，北京肿瘤防治研究会肺癌分委会委员，北京癌症防治学会教育专委会委员。以第一作者发表SCI及国内核心期刊论文近十篇。

出诊时间：周一、二、三上午线上门诊，周五上午线下门诊

发表论文

工作以来，以第一作者发表多篇SCI论文，部分如下：

1) Wang Y, Lian B, Si L, Mao L, Chi Z, Sheng X, Kong Y, Wang X, Bai X, Yan X, Li S, Tang B, Dai J, Zhou L, Wei X, Cui C, Guo J. Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III. European Journal of Cancer. 2022 Nov;175:196-203. IF 10.002

2) Wang Y, Lian B, Si L, Chi Z, Sheng X, Wang X, Mao L, Tang B, Li S, Yan X, Bai X, Zhou L, Cui C, Guo J. Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China. Journal of Cancer Research and Clinical Oncology. 2021 Sep;147(9):2731-2740. IF 4.322

3) Wang Y, Nie J, Dai L, Hu W, Zhang J, Chen X, Ma X, Tian G, Han J, Han S, Wu D, Long J, Zhang Z, Fang J. Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC. Cancer Immunology, Immunotherapy. 2022 Feb;71(2):267-276. IF 6.63

4) Wang Y, Zhang X, Tian D, Han S, Zhang J, Nie J, Dai L, Hu W, Chen X, Ma X, Tian G, Wu D, Zhang Z, Long J, Fang J. Second-line treatment options in advanced thymic carcinoma after failure of platinum-based chemotherapy: A multicenter retrospective study. Cancer Medicine. 2023 Feb;12(3):2303-2311. IF 4.711

5) Wang Y, Nie J, Dai L, Hu W, Chen X, Han J, Ma X, Tian G, Han S, Long J, Zhang Z, Fang J. Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma. Thoracic Cancer. 2019 Jan;10(1):17-23. IF 3.223